MacroGenics Enters Agreement With TerSera For Sale Of Global Rights Of MARGENZA; $40M To Be Paid At Closing And May Receive Additional Sales Milestone Payments Of Up To Of $35M
Portfolio Pulse from Benzinga Newsdesk
MacroGenics has entered an agreement with TerSera for the sale of global rights to MARGENZA. MacroGenics will receive $40M at closing and may receive up to $35M in additional sales milestone payments. The transaction is expected to close in Q4 2024.

October 22, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MacroGenics has agreed to sell the global rights of MARGENZA to TerSera for $40M, with potential additional milestone payments of up to $35M. The deal is expected to close in Q4 2024.
The sale of MARGENZA rights provides immediate cash inflow of $40M and potential future revenue from milestone payments, positively impacting MacroGenics' financial position. The deal's completion in Q4 2024 suggests a future financial boost.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90